Point72 Asset Management Just Bought 6% Of This Biotech Stock
A schedule 13G filed with the SEC last night revealed that Steven Cohen’s Point72 Asset Management purchased a new stake in Agenus Inc (Nasdaq: AGEN). The hedge fund now owns 6,144,144 shares or 6% of the company’s equity. The stock…
Continue reading